In the DLB group, we found that higher plasma levels of GFAP and NfL were associated with greater brain atrophy in medial temporal and frontal brain areas as well as with a higher cerebrovascular lesion load (Fazekas). The gene discussed is NEFL; the disease is Lewy body dementia.